Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Documentation

  • Home >
  • Investors & media >
  • Documentation
22 March 2018
General meetings

Notice of General Meeting on April 12, 2018 Open in new window

22 March 2018
General meetings

Nominees to directorship Open in new window

22 March 2018
General meetings

Proxy Card Open in new window

22 March 2018
General meetings

Supplementary report of the Board on the issuance of ordinary shares on June 22, 2017 Open in new window

22 March 2018
General meetings

Report of auditors on 2017 financial statements in accordance with French GAAP Open in new window

22 March 2018
General meetings

Report of auditors on 2017 consolidated financial statements in accordance with IFRS Open in new window

22 March 2018
General meetings

Auditor’s report on 2017 related party agreements Open in new window

22 March 2018
General meetings

Auditor’s report on resolution number 14 – 2018 General Meeting Open in new window

22 March 2018
General meetings

Auditor’s attestation on the remunerations paid to the five highest-paid people Open in new window

22 March 2018
General meetings

Statement of the number of voting rights – AGM 2018 Open in new window

  • View previous 9 articles
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page